Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly.

Berlie HD, Garwood CL.

Ann Pharmacother. 2010 Apr;44(4):712-7. doi: 10.1345/aph.1M551. Epub 2010 Mar 9. Review.

PMID:
20215495
[PubMed - indexed for MEDLINE]
2.

Comment: diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly.

Eisenhower C, Wilson SA.

Ann Pharmacother. 2010 Dec;44(12):2039; author reply 2039-40. doi: 10.1345/aph.1M551a. Epub 2010 Nov 23. No abstract available.

PMID:
21098746
[PubMed - indexed for MEDLINE]
3.

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.

PMID:
16443869
[PubMed - indexed for MEDLINE]
4.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
[PubMed - indexed for MEDLINE]
5.

Medical therapy for diabetes is associated with increased use of lower endoscopy.

Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, Habel LA.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1195-202.

PMID:
17603822
[PubMed - indexed for MEDLINE]
6.

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.

PMID:
17941873
[PubMed - indexed for MEDLINE]
7.

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947.

PMID:
11874944
[PubMed - indexed for MEDLINE]
8.

Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility.

Maurer MS, Burcham J, Cheng H.

J Gerontol A Biol Sci Med Sci. 2005 Sep;60(9):1157-62.

PMID:
16183956
[PubMed - indexed for MEDLINE]
9.

Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Hermansen K, Mortensen LS.

Drug Saf. 2007;30(12):1127-42. Review.

PMID:
18035865
[PubMed - indexed for MEDLINE]
10.

Pioglitazone/metformin (Actoplus met).

[No authors listed]

Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11. No abstract available.

PMID:
16444136
[PubMed - indexed for MEDLINE]
11.

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group.

N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. Erratum in: N Engl J Med. 2007 Mar 29;356(13):1387-8.

PMID:
17145742
[PubMed - indexed for MEDLINE]
Free Article
12.

Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Johnson JA, Yasui Y.

Diabetologia. 2010 Sep;53(9):1823-6. doi: 10.1007/s00125-010-1780-2. Epub 2010 Jun 4. No abstract available.

PMID:
20523967
[PubMed - indexed for MEDLINE]
13.

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

Meneghini LF, Traylor L, Schwartz SL.

Endocr Pract. 2010 Jul-Aug;16(4):588-99. doi: 10.4158/EP09281.OR.

PMID:
20350924
[PubMed - indexed for MEDLINE]
14.

Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany.

Shearer AT, Bagust A, Liebl A, Schoeffski O, Goertz A.

Pharmacoeconomics. 2006;24 Suppl 1:35-48. Review.

PMID:
16800161
[PubMed - indexed for MEDLINE]
15.

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.

Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.

Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.

PMID:
19591532
[PubMed - indexed for MEDLINE]
16.

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

Health Qual Life Outcomes. 2008 Oct 31;6:88. doi: 10.1186/1477-7525-6-88.

PMID:
18976457
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.

Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A.

Diabetes Obes Metab. 2006 Nov;8(6):650-60.

PMID:
17026489
[PubMed - indexed for MEDLINE]
18.

A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.

Seufert J, L├╝bben G, Dietrich K, Bates PC.

Clin Ther. 2004 Jun;26(6):805-18. Review.

PMID:
15262452
[PubMed - indexed for MEDLINE]
19.

Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer.

Wallace C, Reiber GE, LeMaster J, Smith DG, Sullivan K, Hayes S, Vath C.

Diabetes Care. 2002 Nov;25(11):1983-6.

PMID:
12401743
[PubMed - indexed for MEDLINE]
20.

Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Khanderia U, Pop-Busui R, Eagle KA.

Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Review.

PMID:
18698014
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk